BIVDA Press Releases

23Sep

Press Release - BIVDA IVD Market Audit Results Show COVID-19 Impact

BIVDA Press Release –

 

For Immediate Release

 

---

 

BIVDA IVD Market Audit Results Show COVID-19 Impact

 

  • Report shows substantial impact of COVID-19 pandemic on other diagnostic tests
  • Some diagnostic revenues down by as much as 90%
  • COVID-19 revenues skyrocket

 

The BIVDA Market Audit Report for the first half of 2020 has been published to participants. Twenty seven companies submitted revenue data which has been consolidated into a detailed report on the market size and growth, from totals down to assay level. For the first time Thermofisher Scientific have submitted data for their Microbiology products, further enhancing the coverage of the market which exceeds 95% of the total IVD market excluding Glucose self-tests.

 

The results show a substantial impact of the COVID pandemic and subsequent ‘lockdown’ period on diagnostic tests performed. Although the total market grew by 2.5%, revenues from General Chemistry, Hormones and Tumour Marker tests were reduced by 10 to 15% in the period (and this impact reflects only 3 months of ‘lockdown’ from the half year). Some test revenues were reduced by over 90%, while others increased by as much or more, and revenues from Coronavirus testing became one of the largest categories from negligible levels in 2019.

 

The BIVDA Market Audit is the most accurate and reliable source of data on the UK IVD market available by far, and participation is open to any UK IVD supplier at no cost if a member of BIVDA. Help in data submission, analysis and interpretation is available from BIVDA, and there is now also a website which allows access to data and generation of customised reports for participants.

 

For more information contact John Bagshaw, BIVDA Board Member, at JAB Associates.

 

ENDS --

Related

BIVDA Statement - Blood Collection Tube Shortages

BIVDA has released a statement on the recent Blood Collection Tube shortages being faced by the medi...

Read More >

UK continues to lag behind the European market for in-vitro diagnostic expenditure

IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...

Read More >

BIVDA Press Release - BIVDA welcomes publication of NHS England diagnostics report

 BIVDA welcomes publication of NHS England diagnostics report.  BIVDA has warmly welcomed ...

Read More >

Press Release - BIVDA Comments on COVID-19 antibody test authorisation by Public Health England

Dear All Please see below and attached a press release from BIVDA with a comment from our Chief...

Read More >

BIVDA welcomes publication of Accelerated Access Collaborative’s Our Year in Focus Report

Please see below a press release from BIVDA on the publication of the Accelerated Access Collaborati...

Read More >

NICE launches HealthTech Connect

NICE has launched HealthTech Connect, an online system for identifying and supporting health technol...

Read More >